Want to see SY full AI Analyst Report?
SY Stock Chart & Stats
$2.32
$0.01(0.51%)
At close: 4:00 PM EDT
$2.32
$0.01(0.51%)
Day’s Range― - ―
52-Week Range$1.28 - $4.75
Previous CloseN/A
Volume81.16K
Average Volume (3M)728.21K
Market Cap
$277.70M
Enterprise Value$97.41
Total Cash (Recent Filing)$876.69M
Total Debt (Recent Filing)$379.00M
Price to Earnings (P/E)―
Beta1.01
Next Earnings
Nov 23, 2026EPS Estimate
-0.08Next Dividend Ex-DateN/A
Dividend Yield11.83%
Share Statistics
EPS (TTM)-1.95
Shares Outstanding84,619,710
10 Day Avg. Volume1,842,938
30 Day Avg. Volume728,211
Financial Highlights & Ratios
PEG Ratio0.17
Price to Book (P/B)1.52
Price to Sales (P/S)1.59
P/FCF Ratio-7.80
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-2.36
Revenue Forecast (FY)$2.05B
Bulls Say, Bears Say
Bulls Say
Business ExpansionSoYoung Clinic has quickly expanded with 31 centers in major cities, verifying SY’s strength in differentiating brand position for quality standardized service and value-for-money mindshare for the mass public.
Cash FlowApproximately 80% of aesthetic centers generated positive operating cash flow, demonstrating proven execution for profitable store management.
ValuationA new SOTP framework better captures various SY’s business at different growth phases, with a target price of US$5.5, emphasizing the unique omni-channel advantage for light medical aesthetic services.
Bears Say
Investment RisksInvestment risks include potential price wars on key products, competitors’ subsidies, fluctuating supply chain capabilities, and increasing customer acquisition costs.
SY FAQ
What was So-Young International Inc’s price range in the past 12 months?
So-Young International Inc lowest stock price was $1.28 and its highest was $4.75 in the past 12 months.
What is So-Young International Inc’s market cap?
So-Young International Inc’s market cap is $277.70M.
When is So-Young International Inc’s upcoming earnings report date?
So-Young International Inc’s upcoming earnings report date is Nov 23, 2026 which is in 77 days.
How were So-Young International Inc’s earnings last quarter?
So-Young International Inc released its earnings results on Aug 31, 2026. The company reported -$0.043 earnings per share for the quarter, beating the consensus estimate of -$0.089 by $0.046.
Is So-Young International Inc overvalued?
According to Wall Street analysts So-Young International Inc’s price is currently Overvalued.
Does So-Young International Inc pay dividends?
So-Young International Inc pays a Notavailable dividend of $0.026 which represents an annual dividend yield of 11.83%. See more information on So-Young International Inc dividends here
What is So-Young International Inc’s EPS estimate?
So-Young International Inc’s EPS estimate is -0.08.
How many shares outstanding does So-Young International Inc have?
So-Young International Inc has 84,619,710 shares outstanding.
What happened to So-Young International Inc’s price movement after its last earnings report?
So-Young International Inc reported an EPS of -$0.043 in its last earnings report, beating expectations of -$0.089. Following the earnings report the stock price went up 21.25%.
Which hedge fund is a major shareholder of So-Young International Inc?
Currently, no hedge funds are holding shares in SY
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
So-Young International Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-20.23%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
6.74%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
So-Young International Inc
So-Young International Inc. manages a digital platform specializing in medical aesthetics and elective healthcare services, serving customers in the People's Republic of China and globally. This online ecosystem enables users to explore content, share personal experiences regarding medical aesthetic procedures, and book in-person treatments with various medical aesthetic service providers. The platform also offers resources for researching treatment trends, features ratings and reviews of treatment experiences, and publishes blogs under headings like "Beauty Diaries." Beyond cosmetic enhancements, So-Young facilitates reservations for a broader spectrum of healthcare needs, including dermatology, dentistry (with orthodontics), ophthalmology, comprehensive physical examinations, gynecology, human papillomavirus vaccinations, and postnatal support. The company also supplies Software-as-a-Service (SaaS) solutions and provides guidance and training programs to medical service providers. Its offerings extend to internet information and technology advisory, management consulting, and internet culture services. Furthermore, So-Young is involved in the sale of medical equipment, equipment manufacturing, sales, and agency services, as well as microfinance. As of December 31, 2021, its platform had established connections with approximately 8,400 medical aesthetic service providers and an additional 5,000 providers offering other consumption-focused healthcare services. Established in 2013, So-Young International Inc. maintains its corporate headquarters in Beijing, China.
SY Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call was strongly positive. The company reported record group revenue, approximately 130% year-over-year aesthetic treatment growth, a 37% year-over-year reduction in net loss, improved gross margin, higher same-store sales, expanding clinic profitability and positive operating cash flow across most centers. Management also presented continued product, physician, supply chain and AI initiatives, along with strong revenue guidance for the next quarter. The main negatives were declines in non-clinic business lines, higher cost of revenues and operating expenses, and the continuation of a group-level net loss.View all SY earnings summariesTechnical Analysis
Ownership Overview
0.25% Insiders
0.11% Mutual Funds
3.63% Other Institutional Investors
95.90% Public Companies and
Individual Investors








